Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 267.60
+3.85 (1.46%)
Sep 15, 2025, 3:30 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 41.35 billion as of September 15, 2025. Its market cap has increased by 30.99% in one year.
Market Cap
41.35B
Enterprise Value
59.92B
Revenue
28.96B
Ranking
n/a
PE Ratio
39.07
Stock Price
267.60
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 41.35B, a decrease of -27.22%. That is a compound annual growth rate of -3.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 41.35B | -2.49% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | 21.76B | 59.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,878.76B |
| Divi's Laboratories | 1,599.85B |
| Cipla | 1,271.89B |
| Apollo Hospitals Enterprise | 1,132.23B |
| Mankind Pharma | 1,064.75B |
| Zydus Lifesciences | 1,051.26B |
| Fortis Healthcare | 732.31B |
| Alkem Laboratories | 651.39B |